
A Study Is Starting
A new or upcoming study can introduce its own recruitment plan, patient communications, scheduling needs, and enrollment workflow.
Clinical Trial Enrollment Support
Consent2Randomize can help research sites bring in potential participants, handle the follow-up and early enrollment work after someone shows interest, or both.
Your site decides what C2R handles for the study. That may include recruitment, intake, site-approved preliminary prescreening, follow-up, scheduling, documentation, and a clear handoff to your research team.
Not every study needs outside enrollment support. But a new study, changing patient interest, or a shift in study activity can change what the enrollment work looks like.

A new or upcoming study can introduce its own recruitment plan, patient communications, scheduling needs, and enrollment workflow.

Referrals, sponsor programs, outreach, or recruitment can change the amount and timing of patient interest reaching the site.

Several active studies, a new protocol, or changing study requirements can change which enrollment tasks need attention and when.
The scope can be built around the study and the way your site wants the work handled.

Patient recruitment when additional candidate flow is needed.

Initial response, permitted follow-up, reminders, and keeping the current status clear.

Collecting candidate-reported information and using site-approved preliminary questions.

Helping coordinate permitted appointments and next steps.

Recording what has happened, what is still open, and what the research team needs when it takes over.
C2R handles only the work your site has approved. Your research team remains responsible for formal screening, final eligibility decisions, informed consent, protocol oversight, medical decisions, and randomization.
Study-Specific Support
C2R support is defined around the study. Your site decides what it wants help with, and C2R works within that agreed scope.
Start with the active or upcoming study where enrollment support may be useful.
Agree on the part of recruitment or early enrollment work C2R will support.
C2R handles the agreed work and provides the documentation and handoff defined for the study.
Experience Behind the Approach
C2R draws on hands-on experience supporting research-site prescreening and pre-consent workflows across sponsor-funded clinical trials, including work involving AbbVie, Astellas, Amgen, Gilead Sciences, Janssen, Myovant, Novartis, Pfizer, Regeneron, Receptos, and more.
This describes prior site-level experience and does not imply direct sponsor engagement, current affiliation, or endorsement.
Review the experience behind the C2R approach →Tools & Resources
C2R's resources help research sites examine enrollment workflow, economics, and readiness. The tools support the conversation. C2R can also take on agreed recruitment and early enrollment work for a specific study.
Tell us how you expect recruitment and early enrollment to work for the study. We can look at where C2R may be useful and what your team wants to continue handling.
No PHI needed.